🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Canada / NCT05972005
Recruiting Not applicable

Stronger at Home: Improving Outcomes for Older Adults After Hip Fracture

NCT05972005 · tracked via the Priya Life Science Canada tracker
Sponsor
Dr. Mohammad Auais, PhD
Phase
Not applicable
Started
2023-10-17
Last updated
2026-08-12

Condition(s) studied

Hip Fractures

Investigational drug(s) / intervention(s)

The Intervention (Stronger at Home Intervention)Usual care (Control)

The Intervention (Stronger at Home Intervention): The home-based intervention includes 8 visits by a PT and/or PTA. The PT conducts 3 visits for initial assessment, program design, coaching, and discharge assessments. The program targets personal goals and provides pain self-management support. The second PT visit at 6 weeks allows for reassessment and adjustments. The intervention ensures adherence through multiple sessions, tailored exercises, barrier-solving support, and motivational strategies. The PTA conducts solo visits every other week, assisting with exercises and education under PT supervision. This inclusion reduces wait times and improves efficiency. The clinical team consists of at least 2 PTs and 2 PTAs trained for 3 days. The exercise program adheres to evidence-based principles, involving a 30-minute session with warm-up, exercise, and cool-down. Participants are encouraged to exercise 5 times a week, focusing on strengthening, balance, and functionality. Feasible compliance rates were observed in the pilot study.

Usual care (Control): The control group will receive usual home care provided by the healthcare system, which could vary between cases. We'll document their received care during follow-ups as it is inconsistent and poorly recorded. Regular check-in calls by the study coordinator will remind them of assessments, reducing attrition.

Study summary

The goal of this clinical trial is to compare the effectiveness of a new 14-week individually-tailored home-based rehabilitation program called "Stronger at Home" with usual care in improving functional recovery in community-dwelling older adults after hip fractures.

The main question this trial aims to answer are:

• Is the Stronger at Home program more effective than usual care in improving functional recovery at the end of the 14-week intervention?

secondary questions include:

* What is the cost-utility of the Stronger at Home program compared to usual care at 3.5 months, 6 months, and 12 months after discharge?
* Does the program have a sustained impact on functional recovery at 6 months and 12 months post-discharge?

Participants in the trial will be asked to engage in the following tasks:

* Participate in the Stronger at Home program, which includes using a self-directed toolkit consisting of educational resources and an illustrated exercise program.
* Follow the guidelines provided in the toolkit for gradually increasing exercise intensity and incorporating different types of exercises into their daily life.

The effects of the Stronger at Home program will be compared to those of usual care.

Eligibility

Sex
ALL
Min age
55 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Hip fracture patients who are 55 years or older, * Currently living in the community, and * Either being discharged to their home or a retirement home * Fall from a standing height or less * Live within 45km radius of recruitment site Exclusion Criteria: * Came from long term care or discharged to long term care * Not a hip fracture (e.g., pelvic fracture) * Unable to give consent and no proxy * Fracture due to pathological disease (e.g., cancer, Paget's disease). * Does not speak English and no translator * Fracture sustained at hospital * Terminal illness or exercise contraindications * Discharged with other services not eligible

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Queen's University Kingston Ontario Recruiting

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05972005 on ClinicalTrials.gov ↗ ← All trials in Canada